Login / Signup

Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction.

HyeYon YuJihun AhnByoung Geol ChoiSoohyung ParkDong Oh KangCheol Ung ChoiSeung-Woon RhaMyung Ho Jeong
Published in: Texas Heart Institute journal (2024)
In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.
Keyphrases